Side Effects of Ozempic Injections: What to Expect and When to Call Your Doctor

The most common side effects of Ozempic (semaglutide) injections are stomach-related: nausea, vomiting, diarrhea, constipation, and abdominal pain. They often appear when starting treatment or after an FDA-labeled dose increase. Rare but serious risks include pancreatitis, gallbladder problems, kidney injury from dehydration, thyroid tumor warning, vision changes, and severe allergic reactions [1].

What is Ozempic and how does it work in the body?

Ozempic (semaglutide) is a GLP-1 receptor agonist, a medicine that acts like the natural hormone GLP-1. Under the FDA label, Ozempic is used with diet and exercise to improve blood sugar in adults with type 2 diabetes, to reduce major cardiovascular events in adults with type 2 diabetes and known heart disease, and to reduce certain kidney and heart risks in adults with type 2 diabetes and chronic kidney disease [1].

Semaglutide helps the pancreas release insulin when blood sugar is high, lowers glucagon, slows stomach emptying, and affects appetite signals in the brain [1,4]. These same actions explain why side effects often happen in the stomach and gut.

Semaglutide, the GLP-1 class, and why side effects happen

GLP-1 medicines can make food leave the stomach more slowly. That can help with fullness, but it can also cause nausea, bloating, vomiting, reflux, constipation, or diarrhea [1,4]. Tirzepatide, sold as Mounjaro for type 2 diabetes and Zepbound for chronic weight management, is a related incretin medicine that acts on GIP and GLP-1 receptors; it also has common stomach side effects on its FDA labels [5,6].

Ozempic is not FDA-approved for weight loss. Wegovy (semaglutide, a GLP-1 receptor agonist) is the FDA-approved semaglutide product for chronic weight management in eligible adults and adolescents, while Rybelsus is an oral semaglutide tablet for type 2 diabetes [2,3].

What are the most common side effects of Ozempic injections?

The most common Ozempic injection side effects are nausea, vomiting, diarrhea, abdominal pain, and constipation. In placebo-controlled trials in the FDA label, nausea was reported by 15.8% to 20.3% of people taking Ozempic 0.5 mg or 1 mg, compared with 6.1% taking placebo [1].

Nausea

Nausea is the most reported Ozempic side effect in the FDA label, with rates of 15.8% at 0.5 mg and 20.3% at 1 mg in placebo-controlled trials [1]. It may feel worse after large, greasy, or very sweet meals because semaglutide slows stomach emptying [1].

Vomiting and diarrhea

Vomiting and diarrhea can occur, especially during the first weeks or after dose escalation. In Ozempic label trials, vomiting was reported by 5% to 9.2% of people on 0.5 mg or 1 mg, and diarrhea was reported by 8.5% to 8.8% [1]. Severe vomiting or diarrhea can lead to dehydration, which has been linked to kidney injury in postmarketing reports [1].

Constipation

Constipation is also common. In Ozempic label trials, constipation was reported by 3.1% of people taking 0.5 mg and 5% of people taking 1 mg, compared with 1.5% taking placebo [1]. Severe constipation, ongoing bloating, or inability to keep fluids down should be discussed with a clinician because GLP-1 medicines delay stomach emptying [1].

Abdominal pain

Abdominal pain can be a common side effect, but severe or lasting pain is different. The Ozempic label tells patients to stop the medicine and contact a clinician right away if pancreatitis is suspected, such as severe abdominal pain that may move to the back and may happen with vomiting [1].

Injection site reactions

Injection site reactions can include redness, itching, swelling, or discomfort where the shot was given. The Ozempic label lists injection-site reactions among reported adverse reactions, and severe allergic reactions have also been reported after semaglutide use [1].

Fatigue and headache

Fatigue or headache may happen for several reasons, including lower food intake, dehydration, blood sugar changes, or other medicines. Hypoglycemia is more likely when Ozempic is used with insulin or a sulfonylurea, and the FDA label says clinicians may need to lower those medicines to reduce low blood sugar risk [1].

When do you feel the worst on Ozempic?

Many people feel the most stomach side effects during the first weeks of semaglutide treatment and after each FDA-labeled dose increase. In the Ozempic label, gastrointestinal reactions occurred more often with Ozempic than placebo and were a reason some people stopped treatment [1].

The first weeks and each dose increase

Ozempic has an FDA-labeled starting period of 0.25 mg once weekly for 4 weeks before moving to 0.5 mg once weekly; this early dose is meant for initiation and is not a glycemic-control dose [1]. Side effects may rise when exposure increases, so clinicians usually review nausea, vomiting, diarrhea, constipation, hydration, and blood sugar risk during dose changes [1].

How long side effects usually last

Some stomach effects ease as the body adjusts, but the timeline varies. In clinical trials, gastrointestinal adverse reactions were common and sometimes led to stopping treatment, so symptoms that are severe, lasting, or worsening deserve clinician review [1,11].

What are the serious side effects of Ozempic?

Serious Ozempic side effects are uncommon but important to know. The FDA label warns about pancreatitis, gallbladder disease, acute kidney injury, diabetic retinopathy complications, severe allergic reactions, hypoglycemia with insulin or sulfonylureas, and a boxed warning about thyroid C-cell tumors seen in rodents [1].

Pancreatitis

Pancreatitis means inflammation of the pancreas. The Ozempic label says acute pancreatitis has been observed with GLP-1 receptor agonists and instructs clinicians to stop Ozempic if pancreatitis is suspected; symptoms can include severe belly pain that may spread to the back, with or without vomiting [1].

Gallbladder problems and gallstones

Gallbladder disease, including cholelithiasis, has been reported with Ozempic. In placebo-controlled Ozempic trials, cholelithiasis was reported in 1.5% of people taking 0.5 mg and 0.4% taking 1 mg, and it was not reported in placebo-treated patients [1]. Rapid weight loss itself can also raise gallstone risk, so right-upper-belly pain, fever, or yellowing of the skin should be checked [12].

Kidney injury and dehydration

Acute kidney injury has been reported after nausea, vomiting, diarrhea, or dehydration in people using GLP-1 receptor agonists. The Ozempic label advises monitoring kidney function when severe stomach reactions could cause fluid loss, especially during treatment start or dose escalation [1].

Thyroid tumors and MTC boxed warning

Ozempic carries a boxed warning because semaglutide caused thyroid C-cell tumors in rodents; it is not known whether it causes thyroid C-cell tumors, including medullary thyroid carcinoma, in humans. The FDA label says Ozempic is contraindicated in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [1].

Diabetic retinopathy and vision changes

Diabetic retinopathy complications were reported more often with semaglutide in SUSTAIN-6, a cardiovascular outcomes trial in people with type 2 diabetes at high cardiovascular risk. The Ozempic label advises monitoring patients with a history of diabetic retinopathy [1,8].

Severe allergic reactions

Severe hypersensitivity reactions, including anaphylaxis and angioedema, have been reported with Ozempic. Symptoms such as trouble breathing, swelling of the face or throat, or widespread rash need emergency care [1].

Low blood sugar (hypoglycemia)

Ozempic alone has a lower risk of hypoglycemia than insulin, but low blood sugar risk rises when it is used with insulin or sulfonylurea medicines. The Ozempic label says reducing the insulin or sulfonylurea dose may be needed to lower hypoglycemia risk, which should be handled by a clinician [1].

What organ is Ozempic hardest on?

There is not one organ that Ozempic is always “hardest on.” Most side effects involve the stomach and intestines, while the most important rare risks involve the pancreas, gallbladder, kidneys, eyes in people with diabetic retinopathy, and thyroid C-cell tumor warning [1].

Stomach and gut

The stomach and gut are where most Ozempic side effects show up, especially during the first weeks and dose changes [1]. This is linked to delayed gastric emptying, which can worsen nausea, fullness, reflux, constipation, or vomiting [1,4].

Pancreas

The pancreas matters because pancreatitis has been observed with GLP-1 receptor agonists, including semaglutide. Severe, lasting abdominal pain should not be brushed off because the label instructs stopping Ozempic if pancreatitis is suspected [1].

Gallbladder

The gallbladder can be affected through gallstones or gallbladder inflammation. Ozempic trials reported cholelithiasis, and Wegovy labeling also warns that acute gallbladder disease has occurred with semaglutide treatment [1,2].

Kidneys

The kidneys are usually affected indirectly when vomiting or diarrhea causes dehydration. The Ozempic label advises kidney monitoring when severe gastrointestinal reactions occur, especially when starting or escalating treatment [1].

What are the possible long-term side effects of Ozempic?

Long-term semaglutide data show both benefits and risks, depending on the product, dose, and patient group studied. For Ozempic, long-term safety monitoring focuses on the same labeled risks: gastrointestinal reactions, pancreatitis, gallbladder disease, kidney injury from dehydration, diabetic retinopathy complications, hypoglycemia with certain diabetes medicines, and thyroid tumor warning [1,8].

What long-term trial data show

Semaglutide has been studied in multi-year outcomes trials, including SUSTAIN-6 in type 2 diabetes and SELECT with semaglutide 2.4 mg in adults with overweight or obesity and established cardiovascular disease but without diabetes [8,9]. These trials reported cardiovascular benefit signals in studied groups, but they also tracked adverse events, including gastrointestinal events and gallbladder-related events; individual results vary [8,9].

Weight regain after stopping

Weight regain can happen after stopping semaglutide used for weight management. In the STEP 1 extension, people who stopped semaglutide 2.4 mg regained about two-thirds of prior weight loss over the following year, which shows obesity often needs ongoing care; individual results vary [13].

"Ozempic face" and muscle loss concerns

“Ozempic face” is a popular term for facial volume changes that can happen with weight loss; it is not a separate FDA-labeled diagnosis. In STEP 1, semaglutide 2.4 mg reduced body weight and fat mass, but lean body mass also decreased in absolute terms, which is why clinicians often discuss protein intake, resistance exercise, and side effect monitoring during weight-loss treatment [11].

What should you not eat or drink while on Ozempic?

There is no single food that everyone must avoid on Ozempic, but greasy, very sweet, or very large meals can make nausea, reflux, diarrhea, or stomach pain worse. Alcohol can add blood sugar and dehydration concerns, especially for people with diabetes or vomiting [1,14].

Fried, greasy, and very sweet foods

Greasy or very sweet meals can be harder to tolerate because semaglutide slows stomach emptying, and this effect is part of why nausea is common [1]. Smaller meals, stopping when full, and choosing lower-fat foods may help some people, but severe symptoms should be reviewed by a clinician.

Alcohol and blood sugar

Alcohol can affect blood sugar and may worsen dehydration if vomiting or diarrhea occurs. The American Diabetes Association advises individualized alcohol guidance for people with diabetes, including awareness of delayed hypoglycemia risk when alcohol is used with insulin or insulin secretagogues [14].

Hydration and fiber

Hydration matters because Ozempic-related vomiting or diarrhea can lead to dehydration and kidney injury in rare cases [1]. Fiber can help constipation for many people, but adding too much too fast may worsen gas or bloating, so a clinician or dietitian can help tailor a plan.

How do you reduce or manage Ozempic side effects?

Side effects are often managed by careful dose escalation, smaller meals, hydration, and early clinician follow-up. Do not change your dose schedule on your own; eligibility and dose decisions should be made by a licensed clinician using your history, labs, and current medicines [1].

Dose escalation done slowly

Ozempic labeling uses a 4-week initiation step at 0.25 mg once weekly before 0.5 mg once weekly, with possible increases to 1 mg and 2 mg once weekly if more glycemic control is needed [1]. That is label information, not personal dosing advice; your clinician may pause, adjust, or stop treatment based on side effects and risks.

Meal size, timing, and food choices

Many people tolerate GLP-1 medicines better with smaller meals, slower eating, lower-fat foods, and stopping before feeling overly full. This is consistent with semaglutide’s delayed gastric emptying effect, but these steps do not replace medical review for severe or lasting symptoms [1].

Hydration and electrolytes

Fluids matter most if nausea, vomiting, or diarrhea occur. Because dehydration-related kidney injury has been reported with GLP-1 medicines, contact a clinician if you cannot keep fluids down, feel faint, urinate much less than usual, or have ongoing diarrhea [1].

When to call your clinician

Call your clinician for severe abdominal pain, repeated vomiting, symptoms of dehydration, vision changes, low blood sugar symptoms, gallbladder-type pain, or signs of allergic reaction. Seek emergency care for trouble breathing, swelling of the face or throat, fainting, or severe belly pain [1].

Side effects by dose: 0.25 mg, 0.5 mg, 1 mg, and 2 mg

Ozempic side effects can appear at any dose, but stomach symptoms often show up when treatment starts or the dose is increased. The FDA label lists 0.25 mg once weekly for 4 weeks as the initiation dose, 0.5 mg once weekly after that, and 1 mg or 2 mg once weekly as later options when more glycemic control is needed [1].

Ozempic vs. compounded semaglutide: does the side effect profile differ?

Ozempic is FDA-approved semaglutide made by Novo Nordisk, while compounded semaglutide is prepared by a licensed compounding pharmacy for a specific patient prescription. Compounded semaglutide is not FDA-approved, and FDA does not review compounded drugs for safety, effectiveness, or quality [7].

Compounded semaglutide via a 503A pharmacy may be considered when a clinician determines it is appropriate and it is legally available, but it is not the same as an FDA-approved product. FDA has warned about dosing errors, adverse events, and concerns with some compounded semaglutide products, including products made with salt forms such as semaglutide sodium or semaglutide acetate [7].

How do you get a clinician-reviewed semaglutide prescription and monitor side effects?

A clinician-reviewed semaglutide prescription starts with a medical history, medication review, contraindication check, and a plan for side effect monitoring. Eligibility for GLP-1 therapy is determined by a licensed clinician based on your health history, current medicines, treatment goals, and FDA-approved or clinically appropriate options [1,2,7].

Access can include in-person care, endocrinology or obesity-medicine clinics, and licensed telehealth providers. Chia is one telehealth option that offers clinician evaluation for compounded GLP-1 treatment when appropriate, using prescriptions dispensed through licensed 503A pharmacy partners; compounded products are not FDA-approved and should only be used under a valid prescription [7].

When should you stop Ozempic and seek emergency care?

Seek urgent care for severe allergic symptoms, severe or lasting abdominal pain, signs of pancreatitis, serious dehydration, or severe low blood sugar. The Ozempic label says the medicine should be stopped if pancreatitis is suspected, and severe hypersensitivity reactions need immediate medical care [1].

• Severe belly pain that does not go away, especially if it spreads to the back or comes with vomiting [1]
• Trouble breathing, swelling of the face or throat, fainting, or widespread rash [1]
• Repeated vomiting or diarrhea with dizziness, confusion, very little urination, or inability to keep fluids down [1]
• New or worsening vision changes, especially if you have diabetic retinopathy [1,8]
• Right-upper-belly pain, fever, yellow skin or eyes, or clay-colored stools, which can suggest gallbladder disease [1]
• Shaking, sweating, confusion, fast heartbeat, or fainting that could be low blood sugar, especially if using insulin or sulfonylureas [1]

FDA MedWatch accepts side effect reports online at fda.gov/medwatch or by phone at 1-800-FDA-1088. Reporting does not replace medical care, but it helps FDA track medication safety signals [10].

Keep reading

GLP-1 Weight Loss

Side Effects of Weight Loss Injections: What to Expect from GLP-1 Medications

GLP-1 Medications

Mounjaro Side Effects for Weight Loss: What to Expect and When to Call Your Doctor

GLP-1 Medications

GLP-1 Side Effects: What to Expect and How to Manage Them